Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of Hybridoma
Wu, Paul
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 27 grants from Paul Wu
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Phenotypic screening: high throughput assay development
Pilot Studies Program
Live Attenuated Vaccine Approaches for AIDS
Core - Molecular structure visualization
Monoclonal Antibodies and Immunoassays for Hemoglobin
Recently added grants:
Role of microbiota, host genetics and mesenteric adipose in Crohn's disease fibrosis and post-op recurrence.
Innate Immunity, Cholesterol, and NASH Pathogenesis
Uncovering the rules of gut microbiome strain transmission
Transcriptional Regulation of Wound Healing in Human Gingiva and Skin
Molecular Regulation of MSC fate Decision and Bone Formation by PGC-1a
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44AI062594-003
Application #
3595492
Study Section
Project Start
1986-08-01
Project End
1988-07-31
Budget Start
1987-09-11
Budget End
1988-07-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1987
N44 AI
Production of Hybridoma
Wu, Paul / Genelabs Technologies, Inc.
NIH 1986
N44 AI
Production of Hybridoma
Wu, Paul / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant